Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected to significantly disrupt the pharmaceutical landscape in the country this ...
The newest class of weight-loss drugs—injectable GLP-1 receptor agonist medications originally designed ... deciding to take ...